https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Parental prenatal smoking and risk of childhood acute lymphoblastic leukemia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21565 Sat 24 Mar 2018 07:59:01 AEDT ]]> Maternal dietary intake of folate and vitamins B6 and B12 during pregnancy and risk of childhood brain tumors https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21121 Sat 24 Mar 2018 07:54:00 AEDT ]]> What about school?: educational challenges for children and adolescents with cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26709 Sat 24 Mar 2018 07:26:22 AEDT ]]> Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27000 50. A Cox multivariate regression model for LFS retained both B-other ALL subtype (hazard ratio 4·1, P = 0·0062) and MRD persistence post-HSCT (hazard ratio 3·9, P = 0·0070) as independent adverse prognostic variables. Persistent MRD could be used to direct post-HSCT therapy.]]> Sat 24 Mar 2018 07:25:49 AEDT ]]> COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48191 Sat 11 Mar 2023 12:30:28 AEDT ]]> Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44512 Fri 14 Oct 2022 09:11:36 AEDT ]]>